About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
Symbol
Name
ID
Ryr2
ryanodine receptor 2, cardiac
MGI:99685
88 phenotypes from 28 alleles in 24 genetic backgrounds
Export: Excel File
Allelic Composition
Genetic Background
Annotated Term Reference
Ryr2em1Swch/Ryr2+
involves: 129 * C57BL/6
abnormal action potential J:302151
abnormal heart echocardiography feature J:302151
abnormal myocardial fiber calcium currents J:302151
abnormal myocardial fiber physiology J:302151
abnormal myocardial fiber sodium currents J:302151
decreased heart rate J:302151
decreased response of heart to induced stress J:302151
irregular heartbeat J:302151
Ryr2em1Swch/Ryr2em1Swch
involves: 129 * C57BL/6
prenatal lethality, complete penetrance J:302151
Ryr2M1Btlr/Ryr2M1Btlr
C57BL/6J-Ryr2M1Btlr
increased heart rate J:267528
Ryr2m2Btlr/Ryr2m2Btlr
C57BL/6J-Ryr2m2Btlr
decreased heart rate J:267529
Ryr2m3Btlr/Ryr2m3Btlr
C57BL/6J-Ryr2m3Btlr
decreased heart rate J:267530
Ryr2tm1.1Clhh/Ryr2+
129S/SvEv-Ryr2tm1.1Clhh
abnormal myocardial fiber physiology J:186379
irregular heartbeat J:186379
ventricular tachycardia J:186379
Ryr2tm1.1Clhh/Ryr2tm1.1Clhh
129S/SvEv-Ryr2tm1.1Clhh
abnormal myocardial fiber physiology J:186379
irregular heartbeat J:186379
ventricular tachycardia J:186379
Ryr2tm1.1Hnis/Ryr2tm1.1Hnis
involves: C57BL/6
abnormal mesenteric lymph node morphology J:228787
abnormal spleen white pulp morphology J:228787
normal cardiovascular system phenotype J:228787
enlarged mesenteric lymph nodes J:228787
normal growth/size/body region phenotype J:228787
normal immune system phenotype J:228787
increased spleen weight J:228787
increased thymus weight J:228787
large lymphoid organs J:228787
normal nervous system phenotype J:228787
normal renal/urinary system phenotype J:228787
thymus cortex hyperplasia J:228787
Ryr2tm1.1Hta/Ryr2tm1.1Hta
involves: 129S4/SvJae
abnormal epicardium morphology J:48277
abnormal fetal cardiomyocyte mitochondrial morphology J:48277
abnormal fetal cardiomyocyte morphology J:48277
abnormal fetal cardiomyocyte physiology J:48277
abnormal myocardial trabeculae morphology J:48277
disorganized myocardium J:48277
embryonic growth retardation J:48277
embryonic lethality during organogenesis, complete penetrance J:48277
fetal cardiomyocyte vacuoles J:48277
Ryr2tm1.1Maya/Ryr2+
C57BL/6J-Ryr2tm1.1Maya
abnormal myocardial fiber physiology J:159451
normal behavior/neurological phenotype J:159451
increased physiological sensitivity to xenobiotic J:159451
ventricular tachycardia J:159451
Ryr2tm1.1Msnr/Ryr2+
involves: 129S6/SvEvTac * FVB/N
abnormal heart morphology J:122033
enlarged heart J:122033
Ryr2tm1.1Msnr/Ryr2tm1.1Msnr
involves: 129S6/SvEvTac * FVB/N
cardiac fibrosis J:122033
decreased body weight J:122033
decreased heart left ventricle muscle contractility J:122033
decreased heart rate J:122033
decreased heart ventricle muscle contractility J:122033
enlarged heart J:122033
heart left ventricle hypertrophy J:122033
postnatal lethality, complete penetrance J:122033
thin interventricular septum J:122033
Ryr2tm1.1Swch/Ryr2+
involves: 129S1/Sv * 129X1/SvJ * Black Swiss
increased physiological sensitivity to xenobiotic J:174541
ventricular tachycardia J:174541
Ryr2tm1.1Swch/Ryr2tm2.1Swch
involves: 129S1/Sv * 129X1/SvJ * Black Swiss
abnormal cardiovascular system physiology J:214434
Ryr2tm1.1Wex/Ryr2tm1.1Wex
B6.129S7-Ryr2tm1.1Wex
normal cardiovascular system phenotype J:179475
increased response of heart to induced stress J:179475
ventricular tachycardia J:179475
Ryr2tm1.1Wex/Ryr2tm1.1Wex
involves: 129S7/SvEvBrd
abnormal response of heart to induced stress J:152544
Ryr2tm1Amks/Ryr2tm1Amks
involves: 129S/SvEv * C57BL/6
abnormal response to cardiac infarction J:105666
Ryr2tm1b(KOMP)Wtsi/Ryr2+
C57BL/6N-Ryr2tm1b(KOMP)Wtsi/H
increased startle reflex J:211773
Ryr2tm1b(KOMP)Wtsi/Ryr2tm1b(KOMP)Wtsi
C57BL/6N-Ryr2tm1b(KOMP)Wtsi/H
preweaning lethality, complete penetrance J:211773
Ryr2tm1Hhv/Ryr2tm1Hhv
involves: 129S1/Sv * 129X1/SvJ * FVB/N
abnormal myocardial fiber morphology J:141342
normal cardiovascular system phenotype J:141342
Ryr2tm1Hta/Ryr2tm1Hta
involves: 129S4/SvJae
no abnormal phenotype detected J:48277
Ryr2tm1Krbr/Ryr2tm1Krbr
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N
abnormal atrial thrombosis J:210083
abnormal sinus arrhythmia J:210083
abnormal T wave J:210083
atrioventricular block J:210083
cardiomyopathy J:210083
congestive heart failure J:210083
decreased cardiac output J:210083
decreased heart rate J:210083
increased heart rate J:210083
lethargy J:210083
premature death J:210083
sinus bradycardia J:210083
Ryr2tm1Krbr/Ryr2tm3.1Swch
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
involves: 129S1/Sv * 129X1/SvJ * FVB/N
decreased heart rate J:215190
premature death J:215190
Ryr2tm1Sgp/Ryr2+
involves: 129/Sv * C57BL/6
normal cardiovascular system phenotype J:109683
irregular heartbeat J:109683
ventricular fibrillation J:109683
ventricular tachycardia J:109683
Ryr2tm1Slh/Ryr2+
involves: 129S7/SvEvBrd
abnormal myocardial fiber physiology J:152544
abnormal response of heart to induced stress J:152544
irregular heartbeat J:152544
Ryr2tm1Slh/Ryr2+
involves: 129S7/SvEvBrd * C57BL/6
abnormal myocardial fiber physiology J:111780
cardiomyopathy J:111780
decreased cardiac muscle contractility J:111780
decreased heart right ventricle muscle contractility J:111780
ventricular premature beat J:111780
ventricular tachycardia J:111780
Ryr2tm1Slh/Ryr2+
involves: 129S7/SvEvBrd * C57BL/6J
abnormal afterhyperpolarization J:235432
abnormal brain wave pattern J:235432
abnormal heart electrocardiography waveform feature J:235432
abnormal miniature excitatory postsynaptic currents J:235432
abnormal nervous system electrophysiology J:235432
atrioventricular block J:235432
decreased heart rate J:235432
decreased paired-pulse ratio J:235432
increased susceptibility to induced morbidity/mortality J:235432
increased susceptibility to pharmacologically induced seizures J:235432
irregular heartbeat J:235432
ventricular fibrillation J:235432
Ryr2tm2.1Maya/Ryr2+
involves: C57BL/6J
abnormal myocardial fiber physiology J:186291
normal cardiovascular system phenotype J:186291
ventricular tachycardia J:186291
Ryr2tm2.1Msnr/Ryr2tm2.1Msnr
129S.129P2-Ryr2tm2.1Msnr
abnormal heart left ventricle morphology J:200958
abnormal heart right ventricle morphology J:200958
cardiac hypertrophy J:200958
normal cardiovascular system phenotype J:200958
increased heart weight J:200958
thick interventricular septum J:200958
thick ventricular wall J:200958
Ryr2tm2.1Swch/Ryr2+
involves: 129S1/Sv * 129X1/SvJ * Black Swiss
abnormal cardiac muscle contractility J:214434
abnormal cardiovascular system physiology J:214434
abnormal myocardial fiber physiology J:214434
Ryr2tm2.1Swch/Ryr2tm2.1Swch
involves: 129S1/Sv * 129X1/SvJ * Black Swiss
embryonic lethality during organogenesis, complete penetrance J:214434
Ryr2tm2.1Wex/Ryr2tm2.1Wex
B6.129S7-Ryr2tm2.1Wex
abnormal heart left ventricle morphology J:179475
abnormal myocardial fiber morphology J:179475
absent heartbeat J:179475
normal cardiovascular system phenotype J:179475
decreased cardiac muscle contractility J:179475
decreased heart rate J:179475
increased response of heart to induced stress J:179475
increased susceptibility to induced morbidity/mortality J:179475
ventricular premature beat J:179475
ventricular tachycardia J:179475
Ryr2tm2.1Wex/Ryr2tm2.1Wex
involves: 129S7/SvEvBrd
abnormal sarcoplasmic reticulum morphology J:210426
Ryr2tm2Amks/Ryr2+
B6.129-Ryr2tm2Amks
abnormal brain wave pattern J:137696
abnormal myocardial fiber physiology J:137696
increased response of heart to induced stress J:137696
increased susceptibility to induced morbidity/mortality J:137696
increased susceptibility to pharmacologically induced seizures J:137696
normal nervous system phenotype J:137696
tonic-clonic seizures J:137696
ventricular tachycardia J:137696
Ryr2tm2Amks/Ryr2+
involves: 129S1/Sv * 129X1/SvJ
abnormal myocardial fiber morphology J:212640
abnormal sarcoplasmic reticulum morphology J:212640
atrial fibrillation J:212640
Ryr2tm2Amks/Ryr2tm2Amks
B6.129-Ryr2tm2Amks
decreased survivor rate J:137696
fetal growth retardation J:137696
increased susceptibility to pharmacologically induced seizures J:137696
lethality throughout fetal growth and development, incomplete penetrance J:137696
tonic-clonic seizures J:137696
Ryr2tm2Hhv/Ryr2+
involves: 129 * C57BL/6
abnormal cardiovascular system physiology J:212870
abnormal myocardial fiber physiology J:212870
irregular heartbeat J:212870
ventricular premature beat J:212870
Ryr2tm2Hhv/Ryr2tm2Hhv
involves: 129 * C57BL/6
embryonic lethality, complete penetrance J:212870
Ryr2tm3.1Amks/Ryr2+
involves: C57BL/6
abnormal myocardial fiber morphology J:212640
abnormal sarcoplasmic reticulum morphology J:212640
atrial fibrillation J:212640
Ryr2tm3.1Hhv/Ryr2+
involves: 129S7/SvEvBrd * C57BL/6
abnormal myocardial fiber physiology J:220671
decreased heart rate J:220671
ventricular fibrillation J:220671
Ryr2tm3.1Hhv/Ryr2tm3.1Hhv
involves: 129S7/SvEvBrd * C57BL/6
prenatal lethality, complete penetrance J:220671
Ryr2tm3.1Swch/Ryr2+
involves: 129S1/Sv * 129X1/SvJ
abnormal myocardial fiber physiology J:215190
Ryr2tm3.1Swch/Ryr2tm3.1Swch
involves: 129S1/Sv * 129X1/SvJ
embryonic lethality, complete penetrance J:215190
Ryr2tm4.1Amks/Ryr2+
involves: 129 * C57BL/6
abnormal myocardial fiber morphology J:212640
abnormal sarcoplasmic reticulum morphology J:212640
atrial fibrillation J:212640

Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/19/2024
MGI 6.24
The Jackson Laboratory